Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A clinical deep-dive into the methodological limitations, enrollment biases, generalizability gaps, and conflict-of-interest considerations of the STEP-8 head-to-head trial comparing semaglutide 2.4 mg to liraglutide 3.0 mg for weight management.
Read clinical reviewA deep dive into the STEP-8 trial design, randomization, blinding strategy, estimand framework, and statistical choices that shaped the semaglutide vs liraglutide head-to-head comparison.
Read clinical reviewA deep-dive into the economic modeling, payer-coverage implications, and patient-level value calculations that flow from the STEP-8 head-to-head trial of semaglutide 2.4 mg versus liraglutide 3.0 mg.
Read clinical reviewA deep-dive into the pre-specified and post-hoc subgroup analyses from STEP-8, the first head-to-head RCT of semaglutide 2.4 mg vs liraglutide 3.0 mg, examining which patient profiles drove the largest and smallest weight-loss differences.
Read clinical review